Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.
暂无分享，去创建一个
J. Tcheng | M. Mascelli | R. Maini | C. Wagner | E. Barnathan | T. Schaible | A. Olson | A. Schantz | J. Ford | L. Damaraju | C. L. Wagner | J. Ford | AR Schantz